Brown Cuban propolis (BCP) is the major type of propolis in Cuba; its chemical composition is exclusive and the principal component is nemorosone. In this study we investigated the antiproliferative activity of the ethanol extract of BCP on human breast cancer cell lines. The MTT assay showed a significant antiproliferative activity (P<0.005) of BCP on MCF-7 (estrogen receptor positive ER+) rather than MDA-MB 23 1 (ER-). This effect was concentration-(1-25 µg/mL) and time-(24-48 h) dependent, but it is only partially attributable to apoptosis. Indeed, our data showed that BCP administration to MCF-7 caused a significant (P>0.01) inhibition of cell growth in the G 1 phase of cell cycle, which was mechanism dose-and time-dependent. 17-β Estradiol (10 nM) administration to MCF-7 caused a significant (P<0.001), but not total reduction of BCP antiproliferative activity at concentrations of 1, 5 and 10 µg/mL, but not at the highest concentration (25 µg/mL). The coadministration of ICI 182,780 (100nM), an antagonist of ER, on MCF-7 totally reduced the effect of BCP at 24 h, and showed a significant (P<0.001) reduction of BCP antiproliferative activity at 48 h.
Propolis is a resinous substance with a protective activity against micro-organisms and insects that invade the hives of bees. Propolis has a broad spectrum of biological properties, such as antibacterial, antiviral, antifungal, anti-inflammatory, antioxidant and antitumor activities [1] [2] . Hence, propolis has attracted researchers' interest in the last decades [3] .
The chemical composition of propolis can vary both qualitatively and quantitatively depending on the vegetation where it is produced [4] . Propolis from Europe and China contains many flavonoids and phenolic esters, whereas Chilean propolis is rich in phenols, able to scavenge free radical species and inhibit tumor cell growth [5] . Propolis from Brazil is mainly composed of artepillin C, a flavonoid that exhibits anti-proliferative effects by inhibiting angiogenesis in human lung, stomach and colon cancers and melanoma [6] .
This study was focused on Cuban propolis that has recently attracted attention [7] . Brown Cuban propolis (BCP) is the principal type of Cuban propolis and is derived from Clusia rosea, the principal source of resins in the production of this material [8] [9] [10] [11] . The major constituents are polyisoprenylated benzophenones, the principal one being nemorosone, that has been described as cytotoxic and anti-oxidant [7] [8] [9] . Interestingly, this compound showed cytotoxic activity in vitro against different tumor cell lines, including human cervix carcinoma (HeLa), human larynx carcinoma (Hep-2), prostate carcinoma (PC-3) and central nervous system carcinoma (U251) cells [12] .
The purpose of our study was to evaluate the effect of BCP extract on human breast cancer cells. It is well known that propolis has a great impact in traditional Oriental folk medicine. Indeed, Asian women consuming propolis and traditional isoflavonecontaining diets were more protected from breast cancer [13] . In particular, the ethanolic extract of propolis was found to be more effective than the aqueous extract in inhibiting mammary carcinogenesis [14] . Recently, Song and co-workers [15] demonstrated that the ethanolic extract of propolis from Korea may modulate estrogen receptor activation and more importantly estrogen-dependent breast tumors. Thus, the potential of BCP to protect against breast cancer still remains to be elucidated, as well as the determination of the active components. In this study we observed that BCP can inhibit breast tumor cell growth by arresting the cell cycle in the G0/G1 phase.
Chemical analysis revealed that nemorosone was the main component of the ethanolic extract of BCP, as demonstrated by HPLC-PDA assay. Our experimental procedure was carried out differently from the standard method, at a lower temperature, in order to decrease the co-extraction of waxes, which are inert components of propolis. The concentration of nemorosone in the BCP extract was determined to be 37.8 ± 2 mg/mL.
In order to evaluate whether BCP could exert an antitumor effect on breast cancer, breast cancer cell lines were used, such as MCF-7 andMDA-MB23 1, estrogen receptor positive (ER+) and negative (ER-), respectively. Cells were treated with BCP in a concentration-dependent manner (1-5-10-25 μg/mL). The cytotoxic potential of BCP was tested by means of MTT assay, considered as an index of decreased cell viability and cell growth [16] . The addition of BCP to MCF-7 increased the cell mortality in a concentration-and time-dependent manner (Figure 1a In contrast, administration of BCP on MDA-MB 23 1, ER-cells had no effect at 24 hours. However, at 48 hours the effect was similar to that on MCF-7 cells at 48 hours, implying a cytotoxic effect of the extract on both cells at this experimental time. These results suggested that the potential difference of the BCP effects on MCF-7 and MDA MB231 could be the presence of the estrogen receptor. In order to confirm this hypothesis, we used either the endogenous agonist, 17β-estradiol (E2; 10nM) or the ER antagonist, ICI 182,780 (100nM). As expected, these drugs had no effect on MDA-MB 23 1 (data not shown). Instead, the addition of E2 reduced the capability of BCP to reduce cell viability at 24 hours, but not at 48 hours. ICI 182,780 completely abolished BCP-induced cell mortality on MCF-7 at 24 hours (Figure 2a ), in the same manner as at 48 hours ( Figure 2b ). The BCP vehicle, ethanol and DMSO mixture did not affect either MCF-7 or MDA-MB231 viability (data not shown). To evaluate whether apoptosis may be induced by BCP addition to MCF-7, flow cytometric analysis was performed by means of PI positive staining to distinguish hypodiploid nuclei. Again, a concentration-dependent curve was assessed in a time-dependent manner. BCP induced slight apoptosis at 24 hours in MCF-7 ( Figure 3a ). The mean values were 11.8 ± 0.8% for 1 μg/mL; 17.9 ± 2.1% for 5 μg/mL; 18.2 ± 2.2% for 10 μg/mL and 24 ± 3.1% for 25 μg/mL of administered BCP vs 8.5 ± 0.5% for the control medium (Figure 3a ). The same effect was observed at 48 hours (Figure 3b ). The addition of E2 slightly decreased the apoptosis rate, especially at the highest concentration (Figure 3c , 3d), confirming our previous results.
Chemotherapeutics are usually able to arrest the cell cycle of cancerous cells [17] . Thus, we determined whether our extract was able to exert this type of activity. The addition of BCP to MCF-7 was able to induce arrest in the G0/G1 cell cycle phase in a concentration-dependent manner after 24 hours of treatment (Figure 4a ). This effect was also observed for the cells at 48 hours (Figure 4d ). The G2/M cell cycle phase was not affected (Figure 4c,f) , in contrast to the S phase that was significantly reduced at 24 (Figure 4b ) and 48 hours (Figure 4e ). Propolis has been used for thousands of years in traditional medicine all over the world. The composition of propolis depends on the vegetation of the area from where it was collected and on the bee species [18] . In fact, the chemical composition of propolis from tropical zones is very different from that of temperate zones, as the different vegetation promotes more terpenoids and prenylated derivatives of p-coumaric acids in Brazilian propolis [19] , lignans in Chilean propolis [5] and polyisoprenylated benzophenones in Venezuelan, Brazilian, and Cuban propolis [7] . Brown Cuban propolis (BCP) has a simple and constant chemical composition, of which the major component is nemorosone, a member of the polyisoprenylated benzophenone family. Our study utilized a BCP extract that contained nemorosone as its principal component; the extraction procedures excluded other compounds [7] . Our study revealed that BCP was able to exert an anti-proliferative activity on breast cell line cells. The interesting effect of BCP was its capability to induce cell cycle arrest in the G0/G1 phase. This kind of effect is typical of several anti-tumor chemotherapeutic agents [17] . In a previous report, it was demonstrated that nemorosone may exert a cytotoxic and antioxidant activity on several cancer cell lines [9] . This cytotoxic effect of BCP was observed using the MTT assay. To date, the diminished cell viability had not been ascribed to apoptosis. Indeed, our experimental conditions revealed a very low percentage of hypodiploid nuclei. Instead, cell mortality was more likely defined as increased G1 phase.
Of interest was the observation that the cytotoxic effect of BCP was only evident on MCF-7 cells rather than MDA-MB 23 1, which are ER negative compared with the other ER positive cells. Indeed, the addition of 17β-estradiol reduced the percentage of dead cells compared with BCP administration alone. This surprising effect was attributable to the proliferative effect exerted by estrogen on these cells [20] . Indeed, the addition of ICI 182,780, an ER antagonist, completely abolished the BCP-induced cell mortality on MCF-7. This pharmacological activity was also demonstrated by the use of ER negative cells, such as MDA-MB 23 1, that as expected, were not affected by BCP treatment at 24 hours. Another explanation of our result could be that the receptor activation by the ligand at maximal or sub-maximal concentration may produce a proliferative activity. However, the addition of BCP and E2 did not promote the S and/or G2/M cell cycle phases. Thus, we attributed BCP to an estrogen-like activity. However, further studies need to be conducted to elucidate the real interaction of BCP on ER. Nevertheless, it has been demonstrated that many natural compounds, so called phytoestrogens, have weak in vivo estrogenic activities [21] and their mixed estrogen agonist/antagonist properties are analogous to those of the clinically useful antiestrogen tamoxifen [15, [22] [23] . However, BCP also induced increased cell mortality of MDA-MB 23 1 and MCF-7 at 48 hours. Thus, it cannot be ruled out that BCP could not only interact with ER, but also have an ER-independent activity, as shown on the MDA-MB 231 cell line, which was ER negative, at 48 h.
In fact, it has been demonstrated that nemorosone, the main component of BCP, showed a good cytotoxic activity on a large number of cell lines [9] . So, we can hypothesize that the effect of BCP at 24 h on the estrogen receptor is an early event that follows the activation of other pathways, such as have been reported in the literature [24] .
In conclusion, BCP could prove of potential therapeutic value as an anti-cancer agent. Its antiproliferative and anti-estrogenic activity could shed light on new chemotherapeutic compounds, even though further studies are required to prove its activity in an in vivo breast cancer model.
Experimental
Standard and sample: Brown Cuban propolis (BCP) was provided by "La Estación Experimental Apicola" in Cuba and characterized by spectroscopic techniques, as reported previously [7] . Propolis was kept at 0-5°C and protected from light.
Extraction procedure: The propolis sample was ground prior to extraction. BCP propolis (20 g) was extracted with 80% ethanol (100 mL) by sonicationassisted extraction for 2 h at 20°C.
Quantitative analysis:
A HPLC system including a Surveyor Autosampler, Surveyor LC pump and Surveyor PDA detector (ThermoFinningan, San Jose, CA, USA) and equipped with Xcalibur 3.1 software, was used for quantitative analysis. HPLC separations were performed using a Luna C8 (150 mm x 20 mm i.d., 5 µm) column protected by a guard cartridge (4 mm x 2.0 mm i.d.) and a binary gradient composed of water, solvent A, and acetonitrile, solvent B (linear gradient of B from 55% to 95% for 40 min, isocratic elution of 95% B for 10 min) at a flow rate of 0.2 mL/min. The chromatograms were recorded at 280 nm for quantification. Nemorosone was used as a standard for calibration and an external standard method was utilized for its quantification. The quantitative determination was performed using a four-point regression curve in the range 1-30 µg/mL, and triplicate injections were made for each level. UV peak areas of external standard were plotted against the corresponding standard concentration using weighed linear regression to generate standard curves. BCP hydroalcoholic extract was diluted 100 times and 20 µL of this solution was injected for analysis. The amounts of nemorosone were finally expressed as mg/mL of hydroalcoholic extract. Data are reported as mean±standard deviation (SD) of triplicate determinations.
Chemicals:
Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), trypsin-EDTA (1x) and antibiotic solution (penicillin and streptomycin), and phosphate-buffered saline (PBS) were purchased from Cambrex Biosciences (Microtech, Naples, Italy). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Triton x-100, propidium iodide, 17 β-estradiol and ICI 182,780 were purchased from Sigma (Milan, Italy).
